Company Filing History:
Years Active: 2015
Title: Jongrock Kong: Innovator in Macrolactam Compounds
Introduction
Jongrock Kong is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of chemistry, particularly in the development of macrolactam compounds. His work focuses on innovative processes and intermediates that enhance the preparation of these compounds.
Latest Patents
Jongrock Kong holds a patent for a process and intermediates for preparing macrolactams. The present invention relates to macrolactam compounds, intermediates useful in the preparation of macrolactams, methods for preparing the intermediates, and methods for preparing and modifying macrolactams. One application of the compounds and methods described is in the production of macrolactam compounds that can inhibit HCV NS3 protease activity. An example of an HCV inhibitory compound that can be synthesized using the procedures described is Compound A and its derivatives.
Career Highlights
Jongrock Kong is associated with Merck Sharp & Dohme Corp., where he applies his expertise in the pharmaceutical industry. His work contributes to advancements in drug development and therapeutic solutions.
Collaborations
He has collaborated with notable colleagues, including Cheng Yi Chen and Guy R Humphrey, to further enhance the research and development of macrolactam compounds.
Conclusion
Jongrock Kong's innovative work in the field of macrolactam compounds showcases his dedication to advancing pharmaceutical science. His contributions are vital for the development of new therapeutic agents.